IPO
Valiant Laboratories IPO subscribed 2.19x
The initial public offer (IPO) of Mumbai-based pharma firm Valiant Laboratories was subscribed 2.19 times, led by strong demand from retail investors. The retail category was subscribed 3.14 times and the NII part was booked 1.52 times. The QIB portion was the least subscribed at 1.04. The issue closes on October 3.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
